To compare PacBio long reads with MinION for de novo assembly of bacterial genomes what one should consider for library prep and assembly.
-
-
I am not sure what you are asking for. The PacBio option works: 1 library prep, sequence 1 SMRT-cell & assemble the data - you get a "finished" genome. If playing around with new technology is your goal, then the minion is worth considering. -
If the aim is to compare performance of two platforms. I would use the same sheared and size selected DNA from a bacteria with reference genome to prepare libraries for each platform. Then would sequence them to a certain Mb or Gb (can subsample reads to equal bases if one platform output is higher than the other) and use them for assembly and alignment. Metrics such as N50 (L50), contig number, proportion of data used for assembly, evenness of coverage, gaps and GC biases can be used for comparison.Last edited by nucacidhunter; 06-19-2015, 06:34 PM.Comment
-
Thanks for replies. I wonder if I can use similar approach for transcript isoform analysis.Comment
-
With mapping and assembly of DNA, to a known reference, it is relatively straightforward to determine which platform is better.
With isoform analysis, you're bringing in a huge number of additional variables; you won't know the correct answer, so you will have very little ability to evaluate which platform is doing a better job.Comment
-
I agree with Brian about isoform analysis potential issues. With current knowledge the best option is to access a well annotated fungal species with small genome or C. elegans (to keep sequencing cost down) and prepare full-length dscDNA from mRNA fraction using SMART technology and prepare libraries for both platforms. Transcripts sequences can be used for comparison against annotated regions and genome to compare the coverage of known isoforms and potential new isoform discovery of two platforms.Comment
-
Another option may be to get in touch with the Snyder lab and study the same transcriptomes used in their exploration of PacBio long-reads:
http://www.pnas.org/content/111/27/9869.abstractComment
-
Thank you very much everyone for your posts. I have much clearer idea to plan my Honours project.Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment